AMICUS THERAPEUTICS INC's ticker is and the CUSIP is 03152W959. A total of 4 filers reported holding AMICUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $953 | +251.7% | 78,400 | +263.0% | 0.00% | – |
| Q2 2023 | $271 | +142.0% | 21,600 | +113.9% | 0.00% | – |
| Q1 2023 | $112 | +173.2% | 10,100 | +197.1% | 0.00% | – |
| Q4 2022 | $41 | -100.0% | 3,400 | -72.8% | 0.00% | – |
| Q3 2022 | $130,000 | +21.5% | 12,500 | +25.0% | 0.00% | – |
| Q2 2022 | $107,000 | -9.3% | 10,000 | -20.0% | 0.00% | – |
| Q1 2022 | $118,000 | +24.2% | 12,500 | +50.6% | 0.00% | – |
| Q4 2021 | $95,000 | -87.7% | 8,300 | -89.4% | 0.00% | -100.0% |
| Q3 2021 | $775,000 | +6.5% | 78,500 | +3.8% | 0.00% | 0.0% |
| Q2 2021 | $728,000 | -69.6% | 75,600 | +3015.0% | 0.00% | -75.0% |
| Q1 2021 | $2,397,000 | +346.4% | 2,427 | +941.6% | 0.00% | +300.0% |
| Q4 2020 | $537,000 | -7.6% | 233 | -43.4% | 0.00% | 0.0% |
| Q3 2020 | $581,000 | +91.7% | 412 | +105.0% | 0.00% | – |
| Q2 2020 | $303,000 | -12.4% | 201 | -46.4% | 0.00% | -100.0% |
| Q1 2020 | $346,000 | +208.9% | 375 | +226.1% | 0.00% | – |
| Q4 2019 | $112,000 | +918.2% | 115 | +721.4% | 0.00% | – |
| Q3 2019 | $11,000 | -96.1% | 14 | -93.9% | 0.00% | -100.0% |
| Q2 2019 | $284,000 | +1928.6% | 228 | +1972.7% | 0.00% | – |
| Q1 2019 | $14,000 | -87.7% | 11 | -90.8% | 0.00% | – |
| Q4 2018 | $114,000 | -49.6% | 119 | -36.4% | 0.00% | -100.0% |
| Q3 2018 | $226,000 | -80.8% | 187 | -75.3% | 0.00% | -80.0% |
| Q2 2018 | $1,180,000 | +13011.1% | 756 | +61.5% | 0.01% | – |
| Q1 2018 | $9,000 | -60.9% | 468 | -33.7% | 0.00% | -100.0% |
| Q4 2017 | $23,000 | -61.0% | 706 | -6.0% | 0.00% | -50.0% |
| Q3 2017 | $59,000 | +47.5% | 751 | +24.8% | 0.00% | 0.0% |
| Q2 2017 | $40,000 | -48.1% | 602 | +20.4% | 0.00% | -33.3% |
| Q1 2017 | $77,000 | -22.2% | 500 | +59.2% | 0.00% | -50.0% |
| Q4 2016 | $99,000 | +141.5% | 314 | -52.4% | 0.01% | +100.0% |
| Q3 2016 | $41,000 | +86.4% | 660 | +334.2% | 0.00% | +200.0% |
| Q2 2016 | $22,000 | -24.1% | 152 | +192.3% | 0.00% | -50.0% |
| Q1 2016 | $29,000 | -49.1% | 52 | -78.5% | 0.00% | -50.0% |
| Q4 2015 | $57,000 | -1.7% | 242 | -38.7% | 0.00% | 0.0% |
| Q3 2015 | $58,000 | – | 395 | +206.2% | 0.00% | – |
| Q2 2015 | $0 | -100.0% | 129 | -81.1% | 0.00% | -100.0% |
| Q1 2015 | $19,000 | +35.7% | 684 | +43.7% | 0.00% | 0.0% |
| Q4 2014 | $14,000 | – | 476 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 28,500 | $658,000 | 0.00% |
| JPMORGAN CHASE & CO | 372,500 | $8,601,000 | 0.00% |
| SIMPLEX TRADING, LLC | 233 | $537,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |